CardioBionic Medtech
Revolutionary Artifical Heart Technology. Leading the future of Cardiovascular Care.
Contact Us
Revolutionary Artifical Heart Technology. Leading the future of Cardiovascular Care.
Contact Us
Globally, 30 million people are affected by heart disease, with heart failure as a leading cause of death.
Despite this, only 5,000 donor hearts are available annually, leaving a vast unmet demand for life-saving solutions.
Long-term heart failure is a devastating condition, often leading to a 5-year progression to death when drug therapies fail.
A shortage of donor organs limits transplant options, making Cardiobionic’s artificial heart a crucial alternative.
With heart disease rates rising among older adults, particularly in developed countries, there is a significant demand for advanced cardiac assist devices.
Many patients who cannot receive transplants require an alternative for sustained cardiac support.
Cardiobionic’s artificial heart could serve as a vital alternative for patients who are unable to receive transplants.
Life-Saving Alternative
Affordable and Accessible
Improved Patient Quality of Life
Adaptability and Modularity
Lower Healthcare Costs
Technological Superiority
Scalability for Global Impact